CAMILLE MUNDH: Open Payments
NPI 1083322168 · LIVE OAK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 22 payments from 8 companies in 2025. Trend: 2023 $195 · 2024 $260 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $172 |
| Neurocrine BioSciences, Inc. | 2 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $112 |
| Lundbeck LLC | 4 | $94 |
| Exact Sciences Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| PFIZER INC. | 1 | $16 |
Products named: REXULTI, INGREZZA, CAPLYTA, The Cologuard Plus Collection Kit, MOUNJARO, COBENFY, ABILIFY ASIMTUFII, PAXLOVID.
Industry payments across CA — which companies pay providers there.
